23-GI-133-GI (ML44719): A Phase II, Open-Label, Multi-Cohort, Multicenter Study in Patients With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis

Grants and Contracts Details

StatusActive
Effective start/end date5/21/245/21/26

Funding

  • Genentech Inc: $2.00